Citation: Bairu Meng, Zongji Zhuo, Han Yu, Sining Tao, Zixuan Chen, Erik De Clercq, Christophe Pannecouque, Dongwei Kang, Peng Zhan, Xinyong Liu. Design, synthesis, and biological evaluation of benzo[4,5]thieno[2,3-d]pyrimidine derivatives as novel HIV-1 NNRTIs[J]. Chinese Chemical Letters, ;2024, 35(6): 108827. doi: 10.1016/j.cclet.2023.108827 shu

Design, synthesis, and biological evaluation of benzo[4,5]thieno[2,3-d]pyrimidine derivatives as novel HIV-1 NNRTIs

Bairu Meng ^a ,
Zongji Zhuo ^a ,
Han Yu ^a ,
Sining Tao ^a ,
Zixuan Chen ^a ,
Erik De Clercq ^b ,
Christophe Pannecouque ^b ,
Dongwei Kang ^{a, c, *,} ,
Peng Zhan ^{a, c, *,} ,
Xinyong Liu ^{a, c, *,}

a.
Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Ji'nan 250012, China
b.
Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, K.U. Leuven, Leuven B-3000, Belgium
c.
China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province, Ji'nan 250012, China

kangdongwei@126.com

zhanpeng1982@sdu.edu.cn

xinyongl@sdu.edu.cn

Received Date: 7 June 2023
Revised Date: 18 July 2023
Accepted Date: 19 July 2023
Available Online: 24 July 2023

Figures(5)

Inspired by our previous studies to discover novel human immunodeficiency virus-1 (HIV-1) non-nucleoside reverse transcriptase inhibitors (NNRTIs) by targeting the tolerant region II of the NNRTIs binding pocket (NNIBP), a series of novel benzo[4,5]thieno[2,3-d]pyrimidine derivatives were designed through structure-based drug design as novel potent HIV-1 NNRTIs. The results showed that compound 16b was the most active inhibitor, exhibiting 50% effective concentration (EC₅₀) values from 0.021 µmol/L to 0.298 µmol/L against wild-type (WT) and a panel of NNRTIs-resistant HIV-1 strains. Moreover, 16b was demonstrated with a significantly low 50% cytotoxicity concentration (CC₅₀) value (> 200 µmol/L) and high selectivity index (SI) values. In addition, 16b yielded moderate reverse transcriptase (RT) enzyme inhibition with a 50% inhibition concentration (IC₅₀) value of 0.183 µmol/L, which demonstrated that it acted as HIV-1 NNRTIs. The binding mode of 16b with RT was also illustrated via molecular docking. Overall, this work provided a novel lead compound for developing potent HIV-1 NNRTIs.
- HIV-1,
- NNRTIs,
- DAPYs,
- Tolerant region II,
- Drug design
1. [1]
  HIV data and statistics. https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statistics (2023) (accessed 2022-11-17).
2. [2]
  A.S. Fauci, H.C. Lane, N. Engl. J. Med. 383 (2020) 1–4. doi: 10.1056/NEJMp1916753
3. [3]
  G. Bec, B. Meyer, M.A. Gerard, et al., J. Am. Chem. Soc. 135 (2013) 9743–9752. doi: 10.1021/ja4018418
4. [4]
  A. Tavassoli, Chem. Soc. Rev. 40 (2011) 1337–1346. doi: 10.1039/C0CS00092B
5. [5]
  C. Flexner, Nat. Rev. Drug Discov. 6 (2007) 959–966. doi: 10.1038/nrd2336
6. [6]
  R.J. Shattock, M. Warren, S. McCormack, C.A. Hankins, Science 333 (2011) 42–43. doi: 10.1126/science.1206399
7. [7]
  D. Li, P. Zhan, E. De Clercq, X. Liu, J. Med. Chem. 55 (2012) 3595–3613. doi: 10.1021/jm200990c
8. [8]
  D. Feng, F. Wei, Y. Sun, et al., Chin. Chem. Lett. 32 (2021) 4053–4057. doi: 10.1016/j.cclet.2021.02.033
9. [9]
  D. Feng, H. Lin, L. Jiang, et al., Eur. J. Med. Chem. 246 (2023) 114957. doi: 10.1016/j.ejmech.2022.114957
10. [10]
  F. Zhao, H. Zhang, M. Xie, et al., J. Med. Chem. 66 (2023) 2102–2115. doi: 10.1021/acs.jmedchem.2c01875
11. [11]
  Z. Wang, D. Kang, D. Feng, et al., Eur. J. Med. Chem. 206 (2020) 112811. doi: 10.1016/j.ejmech.2020.112811
12. [12]
  S. Han, Y. Lei, C. Pannecouque, et al., Chin. Chem. Lett. 31 (2020) 764–768. doi: 10.1016/j.cclet.2019.11.020
13. [13]
  Z. Wang, S. Cherukupalli, M. Xie, et al., J. Med. Chem. 65 (2022) 3729–3757. doi: 10.1021/acs.jmedchem.1c01758
14. [14]
  N. Bhavaraju, K. Shears, K. Schwartz, et al., Curr. HIV AIDS Rep. 18 (2021) 508–517. doi: 10.1007/s11904-021-00577-8
15. [15]
  D.A. Lehman, D.C. Wamalwa, C.O. McCoy, et al., J. Acquir. Immune. Defic. Syndr. 60 (2012) 225–233. doi: 10.1097/QAI.0b013e3182515730
16. [16]
  M.E. Cilento, K.A. Kirby, S.G. Sarafianos, Chem. Rev. 121 (2021) 3271–3296. doi: 10.1021/acs.chemrev.0c00967
17. [17]
  A. Olson, N. Bannert, A. Sönnerborg, et al., AIDS 32 (2018) 161–169. doi: 10.1097/QAD.0000000000001689
18. [18]
  D. Kang, F.X. Ruiz, Y. Sun, et al., J. Med. Chem. 64 (2021) 4239–4256. doi: 10.1021/acs.jmedchem.1c00268
19. [19]
  D. Kang, D. Feng, Y. Sun, et al., J. Med. Chem. 63 (2020) 4837–4848. doi: 10.1021/acs.jmedchem.0c00117
20. [20]
  D. Kang, F.X. Ruiz, D. Feng, et al., J. Med. Chem. 63 (2020) 1298–1312. doi: 10.1021/acs.jmedchem.9b01769
21. [21]
  D. Kang, H. Zhang, Z. Wang, et al., J. Med. Chem. 62 (2019) 1484–1501. doi: 10.1021/acs.jmedchem.8b01656
1. [1]
  Kai Tang , Guochao Wei , Peng Zhan . Breaking the impossible: The evolutionary journey of lenacapavir, a long-acting anti-HIV drug. Chinese Chemical Letters, 2025, 36(7): 110500-. doi: 10.1016/j.cclet.2024.110500
2. [2]
  Han Yuan , Fengcai Zhang , Hongzhe Huang , Jiafei Wu , Yi Yang , Wanyi Huang , Dongjing Yang , Zhuoming Li , Zhe Li , Ling Huang , Yi-You Huang , Hai-Bin Luo , Lei Guo . Discovery of 3-trifluoromethyl-substituted pyrazoles as selective phosphodiesterase 10A inhibitors for orally attenuating isoprenaline-induced cardiac hypertrophy. Chinese Chemical Letters, 2025, 36(4): 109965-. doi: 10.1016/j.cclet.2024.109965
3. [3]
  Yi-Ru Bai , Qing-Chuan Duan , Dong-Jie Seng , Ying Xu , Hong-Bo Ren , Jie Zhang , Dan-Dan Shen , Li Yang , Hong-Min Liu , Shuo Yuan . A comprehensive review of small molecule drugs approved by the FDA in 2024: Advance and prospect. Chinese Chemical Letters, 2025, 36(10): 111025-. doi: 10.1016/j.cclet.2025.111025
4. [4]
  Jiawei Zhu , Yucheng Xiong , Xiaoxue Bai , Chenlong Xie , Baichen Xiong , Yao Chen , Haopeng Sun . Small molecule-drug conjugates: Mechanistic insights and strategic design for enhanced cancer therapy. Chinese Chemical Letters, 2025, 36(10): 110799-. doi: 10.1016/j.cclet.2024.110799
5. [5]
  Yuan Xiong , Lan-Hui Qin , Bei Zhao , Lei-Zhi Xu , Yu-Fan Fan , Tian Tian , Hai-Rong Zeng , Ting Liu , Jian Huang , Jian-Ming Sun , Zhen-Hao Tian , Guang-Bo Ge . Structure-based design and development of halogenated-naphthalimides as potent hCYP1B1 inhibitors for overcoming paclitaxel resistance. Chinese Chemical Letters, 2025, 36(11): 110812-. doi: 10.1016/j.cclet.2024.110812
6. [6]
  Yueying Yang , Huiru Xie , Xinbo Yu , Yang Liu , Hui Wang , Hua Li , Lixia Chen . Design, synthesis and evaluation of the first DYRK1A degrader for promoting the proliferation of pancreatic β-cells. Chinese Chemical Letters, 2024, 35(11): 109570-. doi: 10.1016/j.cclet.2024.109570
7. [7]
  Zhenxing Li , Yue Ding , Xinxin Tuo , Jinhong Hu , Taihong Zhang , Xiang Zhou , Liwei Liu , Song Yang . Structure-based drug repurposing targeting pathogenic virus superfamily 1 helicase: An integrated multi-computational screening and bioactivity identification strategy. Chinese Chemical Letters, 2025, 36(9): 110737-. doi: 10.1016/j.cclet.2024.110737
8. [8]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
9. [9]
  Fengjie Liu , Fansu Meng , Zhenjiang Yang , Huan Wang , Yuehong Ren , Yu Cai , Xingwang Zhang . Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters, 2024, 35(9): 109335-. doi: 10.1016/j.cclet.2023.109335
10. [10]
  Yujie Li , Ya-Nan Wang , Yin-Gen Luo , Hongcai Yang , Jinrui Ren , Xiao Li . Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters, 2024, 35(11): 109576-. doi: 10.1016/j.cclet.2024.109576
11. [11]
  Shaoqing Du , Xinyong Liu , Xueping Hu , Peng Zhan . Targeting novel sites represents an effective strategy for combating drug resistance. Chinese Chemical Letters, 2025, 36(1): 110378-. doi: 10.1016/j.cclet.2024.110378
12. [12]
  Qijie Gong , Jian Song , Yihui Song , Kai Tang , Panpan Yang , Xiao Wang , Min Zhao , Liang Ouyang , Li Rao , Bin Yu , Peng Zhan , Saiyang Zhang , Xiaojin Zhang . New techniques and strategies in drug discovery (2020–2024 update). Chinese Chemical Letters, 2025, 36(3): 110456-. doi: 10.1016/j.cclet.2024.110456
13. [13]
  Shifang Song , Chenyu Wu , Li Zhang , Dezhi Yang , Yang Lu , Zhengzheng Zhou . Unpacking phase transitions in multi-component drug systems: A case study. Chinese Chemical Letters, 2025, 36(7): 110911-. doi: 10.1016/j.cclet.2025.110911
14. [14]
  Jing Feng , Yanhong Liu , Liming Gong , Chenfei Liu , Congcong Xiao , Liqing Chen , Mingji Jin , Zhonggao Gao , Wei Huang , Yubo Li . Recent progress on drug delivery systems of regulating intratumoral bacteria for tumor therapy. Chinese Chemical Letters, 2025, 36(11): 110907-. doi: 10.1016/j.cclet.2025.110907
15. [15]
  Bharathi Natarajan , Palanisamy Kannan , Longhua Guo . Metallic nanoparticles for visual sensing: Design, mechanism, and application. Chinese Journal of Structural Chemistry, 2024, 43(9): 100349-100349. doi: 10.1016/j.cjsc.2024.100349
16. [16]
  Shengdong Sun , Cheng Wang , Shikuo Li . Interfacial channel design on the charge migration for photoelectrochemical applications. Chinese Journal of Structural Chemistry, 2024, 43(12): 100398-100398. doi: 10.1016/j.cjsc.2024.100398
17. [17]
  Wenyi Mei , Lijuan Xie , Xiaodong Zhang , Cunjian Shi , Fengzhi Wang , Qiqi Fu , Zhenjiang Zhao , Honglin Li , Yufang Xu , Zhuo Chen . Design, synthesis and biological evaluation of fluorescent derivatives of ursolic acid in living cells. Chinese Chemical Letters, 2024, 35(5): 108825-. doi: 10.1016/j.cclet.2023.108825
18. [18]
  Lingling Su , Qunyan Wu , Congzhi Wang , Jianhui Lan , Weiqun Shi . Theoretical design of polyazole based ligands for the separation of Am(Ⅲ)/Eu(Ⅲ). Chinese Chemical Letters, 2024, 35(8): 109402-. doi: 10.1016/j.cclet.2023.109402
19. [19]
  Pingfan Zhang , Shihuan Hong , Ning Song , Zhonghui Han , Fei Ge , Gang Dai , Hongjun Dong , Chunmei Li . Alloy as advanced catalysts for electrocatalysis: From materials design to applications. Chinese Chemical Letters, 2024, 35(6): 109073-. doi: 10.1016/j.cclet.2023.109073
20. [20]
  Zikang Hu , Hengjie Zhang , Zhengqiu Li , Tianbao Zhao , Zhipeng Gu , Qijuan Yuan , Baoshu Chen . Multifunctional photothermal hydrogels: Design principles, various functions, and promising biological applications. Chinese Chemical Letters, 2024, 35(10): 109527-. doi: 10.1016/j.cclet.2024.109527

Get Citation

PDF

XML

Metrics

PDF Downloads(2)
Abstract views(1003)
HTML views(46)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142